Survival RateDisease-Free SurvivalCell SurvivalSurvival AnalysisTreatment OutcomePrognosisSurvivalKaplan-Meier EstimateAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingRetrospective StudiesGraft SurvivalCombined Modality TherapyFollow-Up StudiesProportional Hazards ModelsNeoplasm Recurrence, LocalTime FactorsTumor Markers, BiologicalChemotherapy, AdjuvantAntineoplastic AgentsBreast NeoplasmsLung NeoplasmsMultivariate AnalysisNeoplasm MetastasisFluorouracilCisplatinAdenocarcinomaDisease ProgressionCyclophosphamideVincristineDoxorubicinLymphatic MetastasisImmunohistochemistryDrug Administration ScheduleRemission InductionLiver NeoplasmsRadiotherapy, AdjuvantCarcinoma, Non-Small-Cell LungBrain NeoplasmsColorectal NeoplasmsProspective StudiesRecurrenceDeoxycytidineCarcinoma, Squamous CellPrednisoneNeoadjuvant TherapyRisk FactorsCohort StudiesSalvage TherapyApoptosisPredictive Value of TestsOvarian NeoplasmsEtoposideAntibodies, Monoclonal, HumanizedOrganoplatinum CompoundsGene Expression Regulation, NeoplasticCarcinomaChemoradiotherapyCell Line, TumorAntimetabolites, AntineoplasticLeucovorinMultiple MyelomaTransplantation, HomologousTaxoidsDacarbazineCarcinoma, HepatocellularTransplantation, AutologousStomach NeoplasmsRadiotherapy DosageAge FactorsNeoplasm InvasivenessPaclitaxelPancreatic NeoplasmsMelanomaCarboplatinVinblastineNeoplasm GradingRisk AssessmentLeukemia, Myeloid, AcuteGlioblastomaHematopoietic Stem Cell TransplantationClinical Trials, Phase III as TopicBone NeoplasmsAntibodies, MonoclonalLymphoma, Large B-Cell, DiffuseRandomized Controlled Trials as TopicRadiotherapyCytarabineMethotrexateSignal TransductionHead and Neck NeoplasmsDrug Resistance, NeoplasmKidney NeoplasmsEsophageal NeoplasmsLife TablesCamptothecinMutationTissue Array AnalysisActuarial AnalysisDose Fractionation